Celeste Lebbe - Dermatologie, Hôpital Saint-Louis, Paris, France

基本信息

浏览量：294

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 82 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Line-field confocal optical coherence tomography in vivo description of Sarcoptes scabiei and histological correlation

Safa Idoudi,Maxime Battistella,Perla El Zeinaty, Clara Tavernier,Celeste Lebbe, Baryour Baroudijian

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2024)

引用0浏览0WOS引用

A Sub-Group of Kidney-Transplant Recipients with Highly Aggressive Squamous Cell Carcinoma Expressing Phosphorylated Serine392p53

Diaddin Hamdan, Charlotte Gardair,Frederic Pamoukdjian, Marie-Noelle Peraldi Gardin, Ines Nakouri,Christophe Leboeuf,Anne Janin,Celeste Lebbe,Maxime Battistella,Guilhem Bousquet

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES（2024）

引用0浏览0WOS引用

Data from Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma Progression

Amina Boussouar,Antonin Tortereau,Ambroise Manceau,Andrea Paradisi,Nicolas Gadot, Jonathan Vial,David Neves,Lionel Larue,Maxime Battistella,Christophe Leboeuf,Celeste Lebbé,Anne Janin,

crossref（2023）

引用0浏览0引用

Delayed Immune-Related Adverse Events (Iraes) On Anti-Pd1-Based Therapy

C. N. Owen,X. Bai, T. Quah,S. Lo,S. Callaghan, C. Martinez-Vila,P. Bhave, I. Reijers, C. L. Gerard, S. Aspelagh,W. Xu,S. J. Welsh,

Annals of Oncology（2020）

引用3浏览0引用

433 Talimogene laherparepvec (T-VEC) in combination with ipilimumab (IPI) versus IPI alone for advanced melanoma: 4-year interim analysis of a randomized, open-label, phase 2 trial

Igor Puzanov,Jason Chesney,Frances Collichio,Parminder Singh,Mohammed Milhem,John Glaspy,Omid Hamid,Merrick Ross,Philip Friedlander,Claus Garbe,Theodore Logan,Axel Hauschild,

Journal for ImmunoTherapy of Cancer（2020）

引用6浏览0引用

Prolonged positive SARS CoV 2 RT PCR in cancer outpatients requires specific reorganization of cancer centres

L. Aguinaga,R. Ursu,J. Legoff, C. Delauguerre,O. Nguyen,S. Harel,B. Royer,M. sebert,M. Jachiet,C. Lebbé,C. Bonnet,P. Brice,

Annals of Oncology（2020）

引用4浏览0引用

LBA45 First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study)

P.A. Ascierto,M. Mandala,P.F. Ferrucci, P. Rutkowski,M. Guidoboni,A.M. Arance Fernandez,V. Ferraresi,E. Maiello,M. Guida,M. Del Vecchio, M.T. Fierro,P. Queirolo,

Annals of Oncology（2020）

引用38浏览0引用

Hépatites aiguës induites par les immunothérapies anti-tumorales (HAII) : aspects cliniques et prise en charge

M.-L. Gauci,B. Baroudjian, U. Bédérède, C. Zéboulon, A. Dupont,J. Delyon, C. Allayous,M. Bagot, I. Madelaine,M. Resche-Rigon,N. Poté, O. Roux,

Annales De Dermatologie Et De Venereologie（2018）

引用0浏览0引用

Automated detection of CTCs/CTMs after size-based selection from blood of patients with melanoma

F. Soussaline, J. Groult, C. Homsy, E. Tatarinova, L. Da-Meda, N. Benali-Furet, F. Ye, A. Papine,G. Uzan,C. Lebbe,J. Wechsler

CLINICAL & EXPERIMENTAL METASTASIS（2018）

引用0浏览0引用

Granulomatose à éosinophiles avec polyangéite induite par des inhibiteurs du checkpoint immunitaire : un premier cas

A. Roger,G. Lorillon,M. Groh, C. Lependu, J. Maillet, D. Arangalage,A. Tazi,C. Lebbe,B. Baroudjian,J. Delyon

Annales De Dermatologie Et De Venereologie（2018）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn